Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 11, 2025

Val66Met and Genetic Predisposition to Obesity, Mood, and Sleep Disorders

View Full Paper
Ask AI
Bookmark
Share

Authors

SSShivangi Sharma

Discussion

Loading...

Member takes

Overview

This review examines val66met polymorphism effects on obesity and mood disorders, indicating potential interventions for health improvement.

Key Points

  • Carriers of the Met allele are more likely to gain weight and experience mood and sleep disorders, indicating significant links between genetics and health.
  • The review highlights val66met's role in disrupted neuroplasticity and emotional regulation, suggesting it could influence various health outcomes.
  • Analysis of existing literature demonstrates that lifestyle changes may increase bdnf levels and counteract some negative effects of the val66met polymorphism.
  • Understanding the val66met polymorphism may lead to personalized strategies for improving physical and mental health outcomes in affected individuals.

Cite This Study

Shivangi Sharma (2025) studied this question.

synapsesocial.com/papers/68a35efb0a429f797332888bhttps://doi.org/10.38124/ijisrt/25jul511
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Role of Physical Activity on Mental Health and Well-Being: A Review2023 · 604 citations
  2. 2Factors that influence participation in physical activity for anxiety or depression: a synthesis of qualitative evidence2020 · 10 citations
  3. 3Genotype-expression interactions for BDNF across human brain regions2021 · 26 citations
  4. 4Association of the brain-derived neurotrophic factor Val66Met polymorphism with body mass index, fasting glucose levels and lipid status in adolescents2020 · 14 citations
  5. 5BDNF Val66Met polymorphism and resilience in major depressive disorder: the impact of cognitive psychotherapy2020 · 27 citations